Literature DB >> 53657

Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

N Eleftheriou, H C Thomas, J Heathcote, S Sherlock.   

Abstract

"e" is a serum antigen associated with type-B hepatitis. It is found only in hepatitis B surface antigen (HBsAg) positive sera, but is antigenically distinct from HBsAg. e antigen was not detected in the serum of any of 99 cases of acute type-B hepatitis who recovered normally. Its antibody, anti-e, was found in 14 (14%). The antibody usually appeared before clearance of HBsAg and before appearance of HBsAb. Serum e was not detected in any of 29 symptom-free carriers of HBsAg, but 21 (73%) showed anti-e. Serum e was found in chronic active hepatitis (44%) and chronic persistent hepatitis (31%). The antibody, however, was detected in only 2 of 79 patients with chronic active hepatitis but in 7 (44%) of chronic persistent hepatitis. Serum e was not found in 5 patients with primary liver-cell carcinoma or 5 with inactive HBsAg-positive cirrhosis. The antibody was, however, found in all 5 of those with inactive cirrhosis and in 4 of the 5 with primary cancer. These results suggest that the presence of e antigen is associated with active and usually continuing liver disease. Anti-e, however, is associated with inactive liver disease and asymptomatic carriage of HBsAg, and its presence must be regarded as a valuable sign in predicting those who will escape progressive chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53657     DOI: 10.1016/s0140-6736(75)92657-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Incidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma.

Authors:  P Coursaget; P Maupas; A Goudeau; J Drucker
Journal:  J Clin Microbiol       Date:  1978-04       Impact factor: 5.948

2.  Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B.

Authors:  H Tsuji; K Murai; K Akagi; M Fujishima
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

3.  Chronic hepatitis.

Authors: 
Journal:  Br Med J       Date:  1977-11-05

4.  Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity.

Authors:  G Pastore; A R Zanetti; P Ferroni; P Dentico; G Angarano; O Schiraldi
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Hepatitis B e-antigen and its correlation with other serological markers in chimpanzees.

Authors:  C M Ling; I K Mushahwar; L R Overby; K R Berquist; J E Maynard
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units.

Authors:  P E Gibson
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

7.  HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

Authors:  R G Chadwick; M F Bassendine; E M Crawford; H C Thomas; S Sherlock
Journal:  Br Med J       Date:  1978-08-19

8.  Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.

Authors:  H F Eggink; H J Houthoff; S Huitema; G Wolters; S Poppema; C H Gips
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

9.  [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].

Authors:  J Knolle; M Born; G Hess; O Klinge; W Arnold; H Bitz; K H Meyer
Journal:  Klin Wochenschr       Date:  1976-06-15

10.  e-Antigen: a link between immune response and infectivity in hepatitis B?

Authors:  G C Turner; H T Green; V D Blundell
Journal:  J Hyg (Lond)       Date:  1978-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.